YearStart
int64 2k
2.02k
| YearEnd
int64 2k
2.02k
| LocationAbbr
stringclasses 55
values | LocationDesc
stringclasses 55
values | DataSource
stringclasses 31
values | Topic
stringclasses 17
values | Question
stringclasses 203
values | Response
float64 | DataValueUnit
stringclasses 12
values | DataValueType
stringclasses 19
values | DataValue
stringlengths 1
95
⌀ | DataValueAlt
float64 0
2.93M
⌀ | DataValueFootnoteSymbol
stringclasses 17
values | DatavalueFootnote
stringclasses 18
values | LowConfidenceLimit
float64 0
1.62k
⌀ | HighConfidenceLimit
float64 0
2.14k
⌀ | StratificationCategory1
stringclasses 3
values | Stratification1
stringclasses 11
values | StratificationCategory2
float64 | Stratification2
float64 | StratificationCategory3
float64 | Stratification3
float64 | GeoLocation
stringclasses 54
values | ResponseID
float64 | LocationID
int64 1
78
| TopicID
stringclasses 17
values | QuestionID
stringclasses 203
values | DataValueTypeID
stringclasses 19
values | StratificationCategoryID1
stringclasses 3
values | StratificationID1
stringclasses 13
values | StratificationCategoryID2
float64 | StratificationID2
float64 | StratificationCategoryID3
float64 | StratificationID3
float64 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2,020 | 2,020 | WI | Wisconsin | BRFSS | Cardiovascular Disease | Influenza vaccination among noninstitutionalized adults aged 18-64 years with a history of coronary heart disease or stroke | null | % | Age-adjusted Prevalence | 52.6 | 52.6 | null | null | 37.8 | 66.9 | Race/Ethnicity | White, non-Hispanic | null | null | null | null | POINT (-89.81637074199966 44.39319117400049) | null | 55 | CVD | CVD9_1 | AGEADJPREV | RACE | WHT | null | null | null | null |
2,020 | 2,020 | VT | Vermont | BRFSS | Nutrition, Physical Activity, and Weight Status | Healthy weight among adults aged >= 18 years | null | % | Crude Prevalence | 36.5 | 36.5 | null | null | 34.6 | 38.4 | Overall | Overall | null | null | null | null | POINT (-72.51764079099962 43.62538123900049) | null | 50 | NPAW | NPAW3_1 | CRDPREV | OVERALL | OVR | null | null | null | null |
2,020 | 2,020 | WA | Washington | BRFSS | Diabetes | Prevalence of diagnosed diabetes among adults aged >= 18 years | null | % | Age-adjusted Prevalence | 7.2 | 7.2 | null | null | 6.6 | 7.8 | Race/Ethnicity | White, non-Hispanic | null | null | null | null | POINT (-120.47001078999972 47.52227862900048) | null | 53 | DIA | DIA2_1 | AGEADJPREV | RACE | WHT | null | null | null | null |
2,020 | 2,020 | VI | Virgin Islands | BRFSS | Tobacco | Current smokeless tobacco use among adults aged >= 18 years | null | % | Crude Prevalence | null | null | - | No data available | null | null | Gender | Female | null | null | null | null | POINT (-64.896335 18.335765) | null | 78 | TOB | TOB2_2 | CRDPREV | GENDER | GENF | null | null | null | null |
2,020 | 2,020 | WA | Washington | BRFSS | Chronic Obstructive Pulmonary Disease | Pneumococcal vaccination among noninstitutionalized adults aged >= 45 years with chronic obstructive pulmonary disease | null | % | Age-adjusted Prevalence | 58.6 | 58.6 | null | null | 49.6 | 67 | Gender | Male | null | null | null | null | POINT (-120.47001078999972 47.52227862900048) | null | 53 | COPD | COPD8_0 | AGEADJPREV | GENDER | GENM | null | null | null | null |
2,020 | 2,020 | WI | Wisconsin | BRFSS | Diabetes | Prevalence of depressive disorders among adults aged >= 18 years with diagnosed diabetes | null | % | Age-adjusted Prevalence | null | null | **** | Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30% | null | null | Race/Ethnicity | Hispanic | null | null | null | null | POINT (-89.81637074199966 44.39319117400049) | null | 55 | DIA | DIA11_3 | AGEADJPREV | RACE | HIS | null | null | null | null |
2,020 | 2,020 | WI | Wisconsin | BRFSS | Mental Health | Recent mentally unhealthy days among adults aged >= 18 years | null | Number | Mean | 4 | 4 | null | null | 3.7 | 4.3 | Race/Ethnicity | White, non-Hispanic | null | null | null | null | POINT (-89.81637074199966 44.39319117400049) | null | 55 | MTH | MTH1_0 | MEAN | RACE | WHT | null | null | null | null |
2,020 | 2,020 | VT | Vermont | BRFSS | Overarching Conditions | Recent physically unhealthy days among adults aged >= 18 years | null | Number | Mean | null | null | **** | Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30% | null | null | Race/Ethnicity | Black, non-Hispanic | null | null | null | null | POINT (-72.51764079099962 43.62538123900049) | null | 50 | OVC | OVC7_1 | MEAN | RACE | BLK | null | null | null | null |
2,020 | 2,020 | VI | Virgin Islands | BRFSS | Tobacco | Current cigarette smoking among women aged 18-44 years | null | % | Crude Prevalence | null | null | - | No data available | null | null | Race/Ethnicity | Other, non-Hispanic | null | null | null | null | POINT (-64.896335 18.335765) | null | 78 | TOB | TOB1_3 | CRDPREV | RACE | OTH | null | null | null | null |
2,020 | 2,020 | WV | West Virginia | BRFSS | Diabetes | Prevalence of depressive disorders among adults aged >= 18 years with diagnosed diabetes | null | % | Crude Prevalence | null | null | **** | Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30% | null | null | Race/Ethnicity | Multiracial, non-Hispanic | null | null | null | null | POINT (-80.71264013499967 38.66551020200046) | null | 54 | DIA | DIA11_3 | CRDPREV | RACE | MRC | null | null | null | null |
2,020 | 2,020 | WA | Washington | BRFSS | Nutrition, Physical Activity, and Weight Status | Overweight or obesity among adults aged >= 18 years | null | % | Crude Prevalence | 70.4 | 70.4 | null | null | 68.8 | 72 | Gender | Male | null | null | null | null | POINT (-120.47001078999972 47.52227862900048) | null | 53 | NPAW | NPAW2_1 | CRDPREV | GENDER | GENM | null | null | null | null |
2,020 | 2,020 | WA | Washington | BRFSS | Cancer | Recent Papanicolaou smear use among women aged 21-44 years | null | % | Crude Prevalence | 77.1 | 77.1 | null | null | 70.1 | 82.9 | Race/Ethnicity | Hispanic | null | null | null | null | POINT (-120.47001078999972 47.52227862900048) | null | 53 | CAN | CAN2_2 | CRDPREV | RACE | HIS | null | null | null | null |
2,020 | 2,020 | VT | Vermont | BRFSS | Overarching Conditions | Recent activity limitation among adults aged >= 18 years | null | Number | Mean | 5.2 | 5.2 | null | null | 3.3 | 7.1 | Race/Ethnicity | Multiracial, non-Hispanic | null | null | null | null | POINT (-72.51764079099962 43.62538123900049) | null | 50 | OVC | OVC7_2 | MEAN | RACE | MRC | null | null | null | null |
2,020 | 2,020 | WY | Wyoming | BRFSS | Immunization | Influenza vaccination among noninstitutionalized adults aged >= 18 years | null | % | Age-adjusted Prevalence | 37 | 37 | null | null | 25.7 | 49.9 | Race/Ethnicity | Other, non-Hispanic | null | null | null | null | POINT (-108.10983035299967 43.23554134300048) | null | 56 | IMM | IMM1_0 | AGEADJPREV | RACE | OTH | null | null | null | null |
2,020 | 2,020 | WV | West Virginia | BRFSS | Oral Health | Visits to dentist or dental clinic among adults aged >= 18 years | null | % | Age-adjusted Prevalence | 54.7 | 54.7 | null | null | 52.1 | 57.2 | Gender | Male | null | null | null | null | POINT (-80.71264013499967 38.66551020200046) | null | 54 | ORH | ORH1_1 | AGEADJPREV | GENDER | GENM | null | null | null | null |
2,020 | 2,020 | VT | Vermont | BRFSS | Arthritis | Arthritis among adults aged >= 18 years | null | % | Crude Prevalence | 26.2 | 26.2 | null | null | 24.8 | 27.7 | Race/Ethnicity | White, non-Hispanic | null | null | null | null | POINT (-72.51764079099962 43.62538123900049) | null | 50 | ART | ART1_1 | CRDPREV | RACE | WHT | null | null | null | null |
2,020 | 2,020 | WA | Washington | BRFSS | Arthritis | Physical inactivity among adults aged >= 18 years with arthritis | null | % | Age-adjusted Prevalence | 29.1 | 29.1 | null | null | 18.1 | 43.2 | Race/Ethnicity | Other, non-Hispanic | null | null | null | null | POINT (-120.47001078999972 47.52227862900048) | null | 53 | ART | ART3_0 | AGEADJPREV | RACE | OTH | null | null | null | null |
2,020 | 2,020 | WI | Wisconsin | BRFSS | Overarching Conditions | Recent physically unhealthy days among adults aged >= 18 years | null | Number | Mean | 3 | 3 | null | null | 2.6 | 3.4 | Gender | Male | null | null | null | null | POINT (-89.81637074199966 44.39319117400049) | null | 55 | OVC | OVC7_1 | MEAN | GENDER | GENM | null | null | null | null |
2,020 | 2,020 | WV | West Virginia | BRFSS | Oral Health | No tooth loss among adults aged 18-64 years | null | % | Age-adjusted Prevalence | 55.4 | 55.4 | null | null | 53.3 | 57.4 | Race/Ethnicity | White, non-Hispanic | null | null | null | null | POINT (-80.71264013499967 38.66551020200046) | null | 54 | ORH | ORH4_3 | AGEADJPREV | RACE | WHT | null | null | null | null |
2,020 | 2,020 | WI | Wisconsin | BRFSS | Overarching Conditions | Prevalence of sufficient sleep among adults aged >= 18 years | null | % | Age-adjusted Prevalence | 67.7 | 67.7 | null | null | 65.5 | 69.8 | Race/Ethnicity | White, non-Hispanic | null | null | null | null | POINT (-89.81637074199966 44.39319117400049) | null | 55 | OVC | OVC8_0 | AGEADJPREV | RACE | WHT | null | null | null | null |
2,020 | 2,020 | VT | Vermont | BRFSS | Asthma | Current asthma prevalence among adults aged >= 18 years | null | % | Age-adjusted Prevalence | null | null | **** | Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30% | null | null | Race/Ethnicity | Black, non-Hispanic | null | null | null | null | POINT (-72.51764079099962 43.62538123900049) | null | 50 | AST | AST1_1 | AGEADJPREV | RACE | BLK | null | null | null | null |
2,020 | 2,020 | WA | Washington | BRFSS | Nutrition, Physical Activity, and Weight Status | Healthy weight among adults aged >= 18 years | null | % | Crude Prevalence | 28.2 | 28.2 | null | null | 26.7 | 29.8 | Gender | Male | null | null | null | null | POINT (-120.47001078999972 47.52227862900048) | null | 53 | NPAW | NPAW3_1 | CRDPREV | GENDER | GENM | null | null | null | null |
2,020 | 2,020 | WV | West Virginia | BRFSS | Arthritis | Physical inactivity among adults aged >= 18 years with arthritis | null | % | Crude Prevalence | 38.6 | 38.6 | null | null | 24.1 | 55.4 | Race/Ethnicity | Black, non-Hispanic | null | null | null | null | POINT (-80.71264013499967 38.66551020200046) | null | 54 | ART | ART3_0 | CRDPREV | RACE | BLK | null | null | null | null |
2,020 | 2,020 | VT | Vermont | BRFSS | Diabetes | Foot examination among adults aged >= 18 years with diagnosed diabetes | null | % | Age-adjusted Prevalence | null | null | - | No data available | null | null | Race/Ethnicity | Other, non-Hispanic | null | null | null | null | POINT (-72.51764079099962 43.62538123900049) | null | 50 | DIA | DIA5_0 | AGEADJPREV | RACE | OTH | null | null | null | null |
2,020 | 2,020 | WI | Wisconsin | BRFSS | Cancer | Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years | null | % | Crude Prevalence | 67.5 | 67.5 | null | null | 65 | 69.9 | Overall | Overall | null | null | null | null | POINT (-89.81637074199966 44.39319117400049) | null | 55 | CAN | CAN3_0 | CRDPREV | OVERALL | OVR | null | null | null | null |
2,020 | 2,020 | WA | Washington | BRFSS | Nutrition, Physical Activity, and Weight Status | Overweight or obesity among adults aged >= 18 years | null | % | Age-adjusted Prevalence | 64.7 | 64.7 | null | null | 63.3 | 66.1 | Race/Ethnicity | White, non-Hispanic | null | null | null | null | POINT (-120.47001078999972 47.52227862900048) | null | 53 | NPAW | NPAW2_1 | AGEADJPREV | RACE | WHT | null | null | null | null |
2,020 | 2,020 | WY | Wyoming | BRFSS | Chronic Obstructive Pulmonary Disease | Prevalence of chronic obstructive pulmonary disease among adults >= 45 years | null | % | Age-adjusted Prevalence | null | null | **** | Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30% | null | null | Race/Ethnicity | Hispanic | null | null | null | null | POINT (-108.10983035299967 43.23554134300048) | null | 56 | COPD | COPD2_0_1 | AGEADJPREV | RACE | HIS | null | null | null | null |
2,020 | 2,020 | WI | Wisconsin | BRFSS | Diabetes | Influenza vaccination among noninstitutionalized adults aged 18-64 years with diagnosed diabetes | null | % | Age-adjusted Prevalence | 57.3 | 57.3 | null | null | 41.5 | 71.8 | Race/Ethnicity | White, non-Hispanic | null | null | null | null | POINT (-89.81637074199966 44.39319117400049) | null | 55 | DIA | DIA12_1 | AGEADJPREV | RACE | WHT | null | null | null | null |
2,020 | 2,020 | WV | West Virginia | BRFSS | Diabetes | Prevalence of diagnosed diabetes among adults aged >= 18 years | null | % | Crude Prevalence | 15.9 | 15.9 | null | null | 14.8 | 17 | Race/Ethnicity | White, non-Hispanic | null | null | null | null | POINT (-80.71264013499967 38.66551020200046) | null | 54 | DIA | DIA2_1 | CRDPREV | RACE | WHT | null | null | null | null |
2,020 | 2,020 | WV | West Virginia | BRFSS | Asthma | Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma | null | % | Crude Prevalence | 87.1 | 87.1 | null | null | 80.8 | 91.5 | Race/Ethnicity | White, non-Hispanic | null | null | null | null | POINT (-80.71264013499967 38.66551020200046) | null | 54 | AST | AST6_2 | CRDPREV | RACE | WHT | null | null | null | null |
2,020 | 2,020 | VT | Vermont | BRFSS | Cardiovascular Disease | Influenza vaccination among noninstitutionalized adults aged 18-64 years with a history of coronary heart disease or stroke | null | % | Crude Prevalence | null | null | **** | Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30% | null | null | Race/Ethnicity | Hispanic | null | null | null | null | POINT (-72.51764079099962 43.62538123900049) | null | 50 | CVD | CVD9_1 | CRDPREV | RACE | HIS | null | null | null | null |
2,020 | 2,020 | WY | Wyoming | BRFSS | Alcohol | Binge drinking intensity among adults aged >= 18 years who binge drink | null | Number | Age-adjusted Mean | null | null | **** | Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30% | null | null | Race/Ethnicity | Hispanic | null | null | null | null | POINT (-108.10983035299967 43.23554134300048) | null | 56 | ALC | ALC4_0 | AGEADJMEAN | RACE | HIS | null | null | null | null |
2,020 | 2,020 | VT | Vermont | BRFSS | Oral Health | Visits to dentist or dental clinic among adults aged >= 18 years | null | % | Age-adjusted Prevalence | 70.5 | 70.5 | null | null | 67.8 | 73.1 | Gender | Female | null | null | null | null | POINT (-72.51764079099962 43.62538123900049) | null | 50 | ORH | ORH1_1 | AGEADJPREV | GENDER | GENF | null | null | null | null |
2,020 | 2,020 | WY | Wyoming | BRFSS | Asthma | Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma | null | % | Age-adjusted Prevalence | null | null | **** | Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30% | null | null | Race/Ethnicity | Hispanic | null | null | null | null | POINT (-108.10983035299967 43.23554134300048) | null | 56 | AST | AST5_1 | AGEADJPREV | RACE | HIS | null | null | null | null |
2,020 | 2,020 | WA | Washington | BRFSS | Cardiovascular Disease | Influenza vaccination among noninstitutionalized adults aged >= 65 years with a history of coronary heart disease or stroke | null | % | Age-adjusted Prevalence | 72.7 | 72.7 | null | null | 67.2 | 77.6 | Race/Ethnicity | White, non-Hispanic | null | null | null | null | POINT (-120.47001078999972 47.52227862900048) | null | 53 | CVD | CVD9_2 | AGEADJPREV | RACE | WHT | null | null | null | null |
2,020 | 2,020 | WA | Washington | BRFSS | Asthma | Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma | null | % | Age-adjusted Prevalence | null | null | **** | Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30% | null | null | Race/Ethnicity | Hispanic | null | null | null | null | POINT (-120.47001078999972 47.52227862900048) | null | 53 | AST | AST6_2 | AGEADJPREV | RACE | HIS | null | null | null | null |
2,020 | 2,020 | WV | West Virginia | BRFSS | Tobacco | Current smokeless tobacco use among adults aged >= 18 years | null | % | Age-adjusted Prevalence | 8.9 | 8.9 | null | null | 7.8 | 10.2 | Race/Ethnicity | White, non-Hispanic | null | null | null | null | POINT (-80.71264013499967 38.66551020200046) | null | 54 | TOB | TOB2_2 | AGEADJPREV | RACE | WHT | null | null | null | null |
2,020 | 2,020 | WV | West Virginia | BRFSS | Mental Health | Recent mentally unhealthy days among adults aged >= 18 years | null | Number | Mean | 7.2 | 7.2 | null | null | 3.6 | 10.8 | Race/Ethnicity | Hispanic | null | null | null | null | POINT (-80.71264013499967 38.66551020200046) | null | 54 | MTH | MTH1_0 | MEAN | RACE | HIS | null | null | null | null |
2,020 | 2,020 | WI | Wisconsin | BRFSS | Alcohol | Heavy drinking among women aged 18-44 years | null | % | Crude Prevalence | null | null | **** | Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30% | null | null | Race/Ethnicity | Other, non-Hispanic | null | null | null | null | POINT (-89.81637074199966 44.39319117400049) | null | 55 | ALC | ALC5_2 | CRDPREV | RACE | OTH | null | null | null | null |
2,020 | 2,020 | WA | Washington | BRFSS | Diabetes | Adults with diagnosed diabetes aged >= 18 years who have taken a diabetes self-management course | null | % | Age-adjusted Prevalence | null | null | - | No data available | null | null | Race/Ethnicity | Hispanic | null | null | null | null | POINT (-120.47001078999972 47.52227862900048) | null | 53 | DIA | DIA10_0 | AGEADJPREV | RACE | HIS | null | null | null | null |
2,020 | 2,020 | WV | West Virginia | BRFSS | Overarching Conditions | Current lack of health insurance among adults aged 18-64 years | null | % | Crude Prevalence | null | null | **** | Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30% | null | null | Race/Ethnicity | Black, non-Hispanic | null | null | null | null | POINT (-80.71264013499967 38.66551020200046) | null | 54 | OVC | OVC1_1 | CRDPREV | RACE | BLK | null | null | null | null |
2,020 | 2,020 | VT | Vermont | BRFSS | Tobacco | Current smokeless tobacco use among adults aged >= 18 years | null | % | Crude Prevalence | 2.4 | 2.4 | null | null | 1.9 | 3.1 | Race/Ethnicity | White, non-Hispanic | null | null | null | null | POINT (-72.51764079099962 43.62538123900049) | null | 50 | TOB | TOB2_2 | CRDPREV | RACE | WHT | null | null | null | null |
2,020 | 2,020 | WV | West Virginia | BRFSS | Tobacco | Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years who smoke | null | % | Age-adjusted Prevalence | null | null | **** | Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30% | null | null | Race/Ethnicity | Hispanic | null | null | null | null | POINT (-80.71264013499967 38.66551020200046) | null | 54 | TOB | TOB11_1 | AGEADJPREV | RACE | HIS | null | null | null | null |
2,020 | 2,020 | VT | Vermont | BRFSS | Chronic Obstructive Pulmonary Disease | Prevalence of current smoking among adults >= 18 with diagnosed chronic obstructive pulmonary disease | null | % | Age-adjusted Prevalence | 54.2 | 54.2 | null | null | 42.7 | 65.2 | Gender | Female | null | null | null | null | POINT (-72.51764079099962 43.62538123900049) | null | 50 | COPD | COPD3_0 | AGEADJPREV | GENDER | GENF | null | null | null | null |
2,020 | 2,020 | WY | Wyoming | BRFSS | Alcohol | Heavy drinking among adults aged >= 18 years | null | % | Age-adjusted Prevalence | null | null | **** | Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30% | null | null | Race/Ethnicity | Other, non-Hispanic | null | null | null | null | POINT (-108.10983035299967 43.23554134300048) | null | 56 | ALC | ALC5_1 | AGEADJPREV | RACE | OTH | null | null | null | null |
2,020 | 2,020 | WI | Wisconsin | BRFSS | Asthma | Current asthma prevalence among adults aged >= 18 years | null | % | Crude Prevalence | 12.8 | 12.8 | null | null | 11 | 14.8 | Gender | Female | null | null | null | null | POINT (-89.81637074199966 44.39319117400049) | null | 55 | AST | AST1_1 | CRDPREV | GENDER | GENF | null | null | null | null |
2,020 | 2,020 | VT | Vermont | BRFSS | Cancer | Papanicolaou smear use among adult women aged 21-65 years | null | % | Age-adjusted Prevalence | 75.5 | 75.5 | null | null | 72.2 | 78.6 | Race/Ethnicity | White, non-Hispanic | null | null | null | null | POINT (-72.51764079099962 43.62538123900049) | null | 50 | CAN | CAN2_1 | AGEADJPREV | RACE | WHT | null | null | null | null |
2,020 | 2,020 | VT | Vermont | BRFSS | Diabetes | Influenza vaccination among noninstitutionalized adults aged 18-64 years with diagnosed diabetes | null | % | Age-adjusted Prevalence | null | null | **** | Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30% | null | null | Race/Ethnicity | Multiracial, non-Hispanic | null | null | null | null | POINT (-72.51764079099962 43.62538123900049) | null | 50 | DIA | DIA12_1 | AGEADJPREV | RACE | MRC | null | null | null | null |
2,020 | 2,020 | WY | Wyoming | BRFSS | Tobacco | Quit attempts in the past year among current smokers | null | % | Crude Prevalence | null | null | **** | Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30% | null | null | Race/Ethnicity | Multiracial, non-Hispanic | null | null | null | null | POINT (-108.10983035299967 43.23554134300048) | null | 56 | TOB | TOB3_0 | CRDPREV | RACE | MRC | null | null | null | null |
2,020 | 2,020 | WA | Washington | BRFSS | Tobacco | Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years who smoke | null | % | Crude Prevalence | null | null | **** | Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30% | null | null | Race/Ethnicity | Other, non-Hispanic | null | null | null | null | POINT (-120.47001078999972 47.52227862900048) | null | 53 | TOB | TOB11_2 | CRDPREV | RACE | OTH | null | null | null | null |
2,020 | 2,020 | WY | Wyoming | BRFSS | Chronic Obstructive Pulmonary Disease | Prevalence of chronic obstructive pulmonary disease among adults >= 18 | null | % | Crude Prevalence | null | null | **** | Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30% | null | null | Race/Ethnicity | Hispanic | null | null | null | null | POINT (-108.10983035299967 43.23554134300048) | null | 56 | COPD | COPD2_0 | CRDPREV | RACE | HIS | null | null | null | null |
2,020 | 2,020 | WV | West Virginia | BRFSS | Diabetes | Influenza vaccination among noninstitutionalized adults aged 18-64 years with diagnosed diabetes | null | % | Age-adjusted Prevalence | null | null | **** | Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30% | null | null | Race/Ethnicity | Hispanic | null | null | null | null | POINT (-80.71264013499967 38.66551020200046) | null | 54 | DIA | DIA12_1 | AGEADJPREV | RACE | HIS | null | null | null | null |
2,020 | 2,020 | WY | Wyoming | BRFSS | Asthma | Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma | null | % | Age-adjusted Prevalence | null | null | **** | Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30% | null | null | Race/Ethnicity | Hispanic | null | null | null | null | POINT (-108.10983035299967 43.23554134300048) | null | 56 | AST | AST6_1 | AGEADJPREV | RACE | HIS | null | null | null | null |
2,020 | 2,020 | WV | West Virginia | BRFSS | Immunization | Influenza vaccination among noninstitutionalized adults aged >= 18 years | null | % | Age-adjusted Prevalence | 33.2 | 33.2 | null | null | 22.7 | 45.8 | Race/Ethnicity | Black, non-Hispanic | null | null | null | null | POINT (-80.71264013499967 38.66551020200046) | null | 54 | IMM | IMM1_0 | AGEADJPREV | RACE | BLK | null | null | null | null |
2,020 | 2,020 | VI | Virgin Islands | BRFSS | Tobacco | Quit attempts in the past year among current smokers | null | % | Crude Prevalence | null | null | - | No data available | null | null | Race/Ethnicity | Hispanic | null | null | null | null | POINT (-64.896335 18.335765) | null | 78 | TOB | TOB3_0 | CRDPREV | RACE | HIS | null | null | null | null |
2,020 | 2,020 | VT | Vermont | BRFSS | Alcohol | Binge drinking prevalence among adults aged >= 18 years | null | % | Age-adjusted Prevalence | null | null | **** | Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30% | null | null | Race/Ethnicity | Multiracial, non-Hispanic | null | null | null | null | POINT (-72.51764079099962 43.62538123900049) | null | 50 | ALC | ALC2_2 | AGEADJPREV | RACE | MRC | null | null | null | null |
2,020 | 2,020 | WI | Wisconsin | BRFSS | Oral Health | Six or more teeth lost among adults aged >= 65 years | null | % | Age-adjusted Prevalence | null | null | **** | Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30% | null | null | Race/Ethnicity | Multiracial, non-Hispanic | null | null | null | null | POINT (-89.81637074199966 44.39319117400049) | null | 55 | ORH | ORH4_2 | AGEADJPREV | RACE | MRC | null | null | null | null |
2,020 | 2,020 | WV | West Virginia | BRFSS | Cancer | Papanicolaou smear use among adult women aged 21-65 years | null | % | Crude Prevalence | null | null | **** | Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30% | null | null | Race/Ethnicity | Multiracial, non-Hispanic | null | null | null | null | POINT (-80.71264013499967 38.66551020200046) | null | 54 | CAN | CAN2_1 | CRDPREV | RACE | MRC | null | null | null | null |
2,020 | 2,020 | WV | West Virginia | BRFSS | Nutrition, Physical Activity, and Weight Status | No leisure-time physical activity among adults aged >= 18 years | null | % | Crude Prevalence | 23.8 | 23.8 | null | null | 14.6 | 36.4 | Race/Ethnicity | Multiracial, non-Hispanic | null | null | null | null | POINT (-80.71264013499967 38.66551020200046) | null | 54 | NPAW | NPAW10_0 | CRDPREV | RACE | MRC | null | null | null | null |
2,020 | 2,020 | WA | Washington | BRFSS | Asthma | Current asthma prevalence among adults aged >= 18 years | null | % | Age-adjusted Prevalence | 5.7 | 5.7 | null | null | 4.2 | 7.6 | Race/Ethnicity | Other, non-Hispanic | null | null | null | null | POINT (-120.47001078999972 47.52227862900048) | null | 53 | AST | AST1_1 | AGEADJPREV | RACE | OTH | null | null | null | null |
2,020 | 2,020 | VT | Vermont | BRFSS | Arthritis | Fair or poor health among adults aged >= 18 years with arthritis | null | % | Crude Prevalence | 23.7 | 23.7 | null | null | 19.8 | 28.2 | Gender | Male | null | null | null | null | POINT (-72.51764079099962 43.62538123900049) | null | 50 | ART | ART4_0 | CRDPREV | GENDER | GENM | null | null | null | null |
2,020 | 2,020 | VT | Vermont | BRFSS | Arthritis | Arthritis among adults aged >= 18 years who have heart disease | null | % | Age-adjusted Prevalence | 46.1 | 46.1 | null | null | 34.9 | 57.7 | Race/Ethnicity | White, non-Hispanic | null | null | null | null | POINT (-72.51764079099962 43.62538123900049) | null | 50 | ART | ART1_4 | AGEADJPREV | RACE | WHT | null | null | null | null |
2,020 | 2,020 | WA | Washington | BRFSS | Chronic Obstructive Pulmonary Disease | Pneumococcal vaccination among noninstitutionalized adults aged >= 45 years with chronic obstructive pulmonary disease | null | % | Crude Prevalence | null | null | **** | Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30% | null | null | Race/Ethnicity | Other, non-Hispanic | null | null | null | null | POINT (-120.47001078999972 47.52227862900048) | null | 53 | COPD | COPD8_0 | CRDPREV | RACE | OTH | null | null | null | null |
2,020 | 2,020 | WV | West Virginia | BRFSS | Asthma | Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma | null | % | Crude Prevalence | 53.1 | 53.1 | null | null | 43.8 | 62.1 | Gender | Male | null | null | null | null | POINT (-80.71264013499967 38.66551020200046) | null | 54 | AST | AST6_1 | CRDPREV | GENDER | GENM | null | null | null | null |
2,020 | 2,020 | WV | West Virginia | BRFSS | Cancer | Recent Papanicolaou smear use among women aged 21-44 years | null | % | Crude Prevalence | 79.8 | 79.8 | null | null | 75.9 | 83.1 | Overall | Overall | null | null | null | null | POINT (-80.71264013499967 38.66551020200046) | null | 54 | CAN | CAN2_2 | CRDPREV | OVERALL | OVR | null | null | null | null |
2,020 | 2,020 | WI | Wisconsin | BRFSS | Diabetes | Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with diagnosed diabetes | null | % | Crude Prevalence | null | null | **** | Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30% | null | null | Race/Ethnicity | Multiracial, non-Hispanic | null | null | null | null | POINT (-89.81637074199966 44.39319117400049) | null | 55 | DIA | DIA13_2 | CRDPREV | RACE | MRC | null | null | null | null |
2,020 | 2,020 | WY | Wyoming | BRFSS | Alcohol | Binge drinking intensity among adults aged >= 18 years who binge drink | null | Number | Age-adjusted Mean | 7.2 | 7.2 | null | null | 6.8 | 7.7 | Overall | Overall | null | null | null | null | POINT (-108.10983035299967 43.23554134300048) | null | 56 | ALC | ALC4_0 | AGEADJMEAN | OVERALL | OVR | null | null | null | null |
2,020 | 2,020 | WY | Wyoming | BRFSS | Overarching Conditions | Self-rated health status among women aged 18-44 years | null | % | Crude Prevalence | null | null | **** | Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30% | null | null | Race/Ethnicity | Other, non-Hispanic | null | null | null | null | POINT (-108.10983035299967 43.23554134300048) | null | 56 | OVC | OVC6_2 | CRDPREV | RACE | OTH | null | null | null | null |
2,020 | 2,020 | VT | Vermont | BRFSS | Asthma | Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma | null | % | Crude Prevalence | 43.5 | 43.5 | null | null | 36.5 | 50.8 | Overall | Overall | null | null | null | null | POINT (-72.51764079099962 43.62538123900049) | null | 50 | AST | AST6_1 | CRDPREV | OVERALL | OVR | null | null | null | null |
2,020 | 2,020 | WY | Wyoming | BRFSS | Diabetes | Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with diagnosed diabetes | null | % | Crude Prevalence | 62.1 | 62.1 | null | null | 48.8 | 73.8 | Gender | Male | null | null | null | null | POINT (-108.10983035299967 43.23554134300048) | null | 56 | DIA | DIA13_1 | CRDPREV | GENDER | GENM | null | null | null | null |
2,020 | 2,020 | VT | Vermont | BRFSS | Chronic Obstructive Pulmonary Disease | Prevalence of chronic obstructive pulmonary disease among adults >= 45 years | null | % | Crude Prevalence | 8.5 | 8.5 | null | null | 7.4 | 9.6 | Race/Ethnicity | White, non-Hispanic | null | null | null | null | POINT (-72.51764079099962 43.62538123900049) | null | 50 | COPD | COPD2_0_1 | CRDPREV | RACE | WHT | null | null | null | null |
2,020 | 2,020 | WY | Wyoming | BRFSS | Cardiovascular Disease | Influenza vaccination among noninstitutionalized adults aged >= 65 years with a history of coronary heart disease or stroke | null | % | Age-adjusted Prevalence | 63.9 | 63.9 | null | null | 55.1 | 71.8 | Race/Ethnicity | White, non-Hispanic | null | null | null | null | POINT (-108.10983035299967 43.23554134300048) | null | 56 | CVD | CVD9_2 | AGEADJPREV | RACE | WHT | null | null | null | null |
2,020 | 2,020 | WI | Wisconsin | BRFSS | Diabetes | Adults with diagnosed diabetes aged >= 18 years who have taken a diabetes self-management course | null | % | Crude Prevalence | null | null | **** | Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30% | null | null | Race/Ethnicity | Other, non-Hispanic | null | null | null | null | POINT (-89.81637074199966 44.39319117400049) | null | 55 | DIA | DIA10_0 | CRDPREV | RACE | OTH | null | null | null | null |
2,020 | 2,020 | WI | Wisconsin | BRFSS | Mental Health | At least 14 recent mentally unhealthy days among women aged 18-44 years | null | % | Crude Prevalence | null | null | **** | Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30% | null | null | Race/Ethnicity | Multiracial, non-Hispanic | null | null | null | null | POINT (-89.81637074199966 44.39319117400049) | null | 55 | MTH | MTH2_0 | CRDPREV | RACE | MRC | null | null | null | null |
2,020 | 2,020 | WI | Wisconsin | BRFSS | Chronic Obstructive Pulmonary Disease | Influenza vaccination among noninstitutionalized adults aged >= 45 years with chronic obstructive pulmonary disease | null | % | Crude Prevalence | null | null | **** | Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30% | null | null | Race/Ethnicity | Other, non-Hispanic | null | null | null | null | POINT (-89.81637074199966 44.39319117400049) | null | 55 | COPD | COPD7_0 | CRDPREV | RACE | OTH | null | null | null | null |
2,020 | 2,020 | VT | Vermont | BRFSS | Nutrition, Physical Activity, and Weight Status | No leisure-time physical activity among adults aged >= 18 years | null | % | Age-adjusted Prevalence | 16.7 | 16.7 | null | null | 15.3 | 18.2 | Race/Ethnicity | White, non-Hispanic | null | null | null | null | POINT (-72.51764079099962 43.62538123900049) | null | 50 | NPAW | NPAW10_0 | AGEADJPREV | RACE | WHT | null | null | null | null |
2,020 | 2,020 | WV | West Virginia | BRFSS | Asthma | Asthma prevalence among women aged 18-44 years | null | % | Crude Prevalence | null | null | **** | Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30% | null | null | Race/Ethnicity | Hispanic | null | null | null | null | POINT (-80.71264013499967 38.66551020200046) | null | 54 | AST | AST1_2 | CRDPREV | RACE | HIS | null | null | null | null |
2,020 | 2,020 | WY | Wyoming | BRFSS | Overarching Conditions | Fair or poor self-rated health status among adults aged >= 18 years | null | % | Age-adjusted Prevalence | 11 | 11 | null | null | 9.3 | 13 | Gender | Male | null | null | null | null | POINT (-108.10983035299967 43.23554134300048) | null | 56 | OVC | OVC6_1 | AGEADJPREV | GENDER | GENM | null | null | null | null |
2,020 | 2,020 | WV | West Virginia | BRFSS | Nutrition, Physical Activity, and Weight Status | No leisure-time physical activity among adults aged >= 18 years | null | % | Crude Prevalence | 33.2 | 33.2 | null | null | 31.3 | 35.2 | Gender | Female | null | null | null | null | POINT (-80.71264013499967 38.66551020200046) | null | 54 | NPAW | NPAW10_0 | CRDPREV | GENDER | GENF | null | null | null | null |
2,020 | 2,020 | WY | Wyoming | BRFSS | Diabetes | Prevalence of depressive disorders among adults aged >= 18 years with diagnosed diabetes | null | % | Age-adjusted Prevalence | 8.5 | 8.5 | null | null | 5.4 | 13 | Gender | Male | null | null | null | null | POINT (-108.10983035299967 43.23554134300048) | null | 56 | DIA | DIA11_3 | AGEADJPREV | GENDER | GENM | null | null | null | null |
2,020 | 2,020 | WY | Wyoming | BRFSS | Nutrition, Physical Activity, and Weight Status | Overweight or obesity among adults aged >= 18 years | null | % | Age-adjusted Prevalence | 67.2 | 67.2 | null | null | 65 | 69.3 | Overall | Overall | null | null | null | null | POINT (-108.10983035299967 43.23554134300048) | null | 56 | NPAW | NPAW2_1 | AGEADJPREV | OVERALL | OVR | null | null | null | null |
2,020 | 2,020 | WV | West Virginia | BRFSS | Cardiovascular Disease | Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with a history of coronary heart disease | null | % | Crude Prevalence | null | null | **** | Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30% | null | null | Race/Ethnicity | Multiracial, non-Hispanic | null | null | null | null | POINT (-80.71264013499967 38.66551020200046) | null | 54 | CVD | CVD10_2 | CRDPREV | RACE | MRC | null | null | null | null |
2,020 | 2,020 | WV | West Virginia | BRFSS | Asthma | Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma | null | % | Age-adjusted Prevalence | 63 | 63 | null | null | 51.4 | 73.2 | Gender | Female | null | null | null | null | POINT (-80.71264013499967 38.66551020200046) | null | 54 | AST | AST5_2 | AGEADJPREV | GENDER | GENF | null | null | null | null |
2,020 | 2,020 | WA | Washington | BRFSS | Asthma | Current asthma prevalence among adults aged >= 18 years | null | % | Crude Prevalence | 6.9 | 6.9 | null | null | 6.1 | 7.7 | Gender | Male | null | null | null | null | POINT (-120.47001078999972 47.52227862900048) | null | 53 | AST | AST1_1 | CRDPREV | GENDER | GENM | null | null | null | null |
2,020 | 2,020 | WY | Wyoming | BRFSS | Oral Health | Visits to dentist or dental clinic among adults aged >= 18 years | null | % | Age-adjusted Prevalence | 65.9 | 65.9 | null | null | 63.5 | 68.2 | Race/Ethnicity | White, non-Hispanic | null | null | null | null | POINT (-108.10983035299967 43.23554134300048) | null | 56 | ORH | ORH1_1 | AGEADJPREV | RACE | WHT | null | null | null | null |
2,020 | 2,020 | VT | Vermont | BRFSS | Asthma | Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma | null | % | Age-adjusted Prevalence | null | null | **** | Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30% | null | null | Race/Ethnicity | Multiracial, non-Hispanic | null | null | null | null | POINT (-72.51764079099962 43.62538123900049) | null | 50 | AST | AST6_1 | AGEADJPREV | RACE | MRC | null | null | null | null |
2,020 | 2,020 | VT | Vermont | BRFSS | Alcohol | Binge drinking frequency among adults aged >= 18 years who binge drink | null | Number | Mean | 4.5 | 4.5 | null | null | 3.7 | 5.4 | Gender | Female | null | null | null | null | POINT (-72.51764079099962 43.62538123900049) | null | 50 | ALC | ALC3_0 | MEAN | GENDER | GENF | null | null | null | null |
2,020 | 2,020 | WY | Wyoming | BRFSS | Asthma | Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma | null | % | Crude Prevalence | null | null | **** | Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30% | null | null | Race/Ethnicity | Multiracial, non-Hispanic | null | null | null | null | POINT (-108.10983035299967 43.23554134300048) | null | 56 | AST | AST5_2 | CRDPREV | RACE | MRC | null | null | null | null |
2,020 | 2,020 | WV | West Virginia | BRFSS | Tobacco | Current smokeless tobacco use among adults aged >= 18 years | null | % | Crude Prevalence | null | null | **** | Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30% | null | null | Race/Ethnicity | Hispanic | null | null | null | null | POINT (-80.71264013499967 38.66551020200046) | null | 54 | TOB | TOB2_2 | CRDPREV | RACE | HIS | null | null | null | null |
2,020 | 2,020 | WI | Wisconsin | BRFSS | Arthritis | Arthritis among adults aged >= 18 years who have heart disease | null | % | Age-adjusted Prevalence | 29.7 | 29.7 | null | null | 23.9 | 36.2 | Overall | Overall | null | null | null | null | POINT (-89.81637074199966 44.39319117400049) | null | 55 | ART | ART1_4 | AGEADJPREV | OVERALL | OVR | null | null | null | null |
2,020 | 2,020 | WY | Wyoming | BRFSS | Cardiovascular Disease | Influenza vaccination among noninstitutionalized adults aged 18-64 years with a history of coronary heart disease or stroke | null | % | Crude Prevalence | null | null | **** | Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30% | null | null | Race/Ethnicity | Hispanic | null | null | null | null | POINT (-108.10983035299967 43.23554134300048) | null | 56 | CVD | CVD9_1 | CRDPREV | RACE | HIS | null | null | null | null |
2,020 | 2,020 | WA | Washington | BRFSS | Diabetes | Influenza vaccination among noninstitutionalized adults aged 18-64 years with diagnosed diabetes | null | % | Age-adjusted Prevalence | 53 | 53 | null | null | 35.7 | 69.7 | Race/Ethnicity | Hispanic | null | null | null | null | POINT (-120.47001078999972 47.52227862900048) | null | 53 | DIA | DIA12_1 | AGEADJPREV | RACE | HIS | null | null | null | null |
2,020 | 2,020 | WI | Wisconsin | BRFSS | Tobacco | Current smokeless tobacco use among adults aged >= 18 years | null | % | Age-adjusted Prevalence | null | null | **** | Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30% | null | null | Race/Ethnicity | Other, non-Hispanic | null | null | null | null | POINT (-89.81637074199966 44.39319117400049) | null | 55 | TOB | TOB2_2 | AGEADJPREV | RACE | OTH | null | null | null | null |
2,020 | 2,020 | VT | Vermont | BRFSS | Chronic Obstructive Pulmonary Disease | Prevalence of chronic obstructive pulmonary disease among adults >= 18 | null | % | Age-adjusted Prevalence | 5.6 | 5.6 | null | null | 4.8 | 6.6 | Gender | Female | null | null | null | null | POINT (-72.51764079099962 43.62538123900049) | null | 50 | COPD | COPD2_0 | AGEADJPREV | GENDER | GENF | null | null | null | null |
2,020 | 2,020 | WA | Washington | BRFSS | Oral Health | All teeth lost among adults aged >= 65 years | null | % | Crude Prevalence | null | null | **** | Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30% | null | null | Race/Ethnicity | Other, non-Hispanic | null | null | null | null | POINT (-120.47001078999972 47.52227862900048) | null | 53 | ORH | ORH4_1 | CRDPREV | RACE | OTH | null | null | null | null |
2,020 | 2,020 | WY | Wyoming | BRFSS | Chronic Obstructive Pulmonary Disease | Prevalence of current smoking among adults >= 18 with diagnosed chronic obstructive pulmonary disease | null | % | Crude Prevalence | 28.3 | 28.3 | null | null | 22.1 | 35.5 | Race/Ethnicity | White, non-Hispanic | null | null | null | null | POINT (-108.10983035299967 43.23554134300048) | null | 56 | COPD | COPD3_0 | CRDPREV | RACE | WHT | null | null | null | null |
2,020 | 2,020 | WA | Washington | BRFSS | Asthma | Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma | null | % | Age-adjusted Prevalence | null | null | **** | Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30% | null | null | Race/Ethnicity | Hispanic | null | null | null | null | POINT (-120.47001078999972 47.52227862900048) | null | 53 | AST | AST5_2 | AGEADJPREV | RACE | HIS | null | null | null | null |
2,020 | 2,020 | VT | Vermont | BRFSS | Overarching Conditions | Current lack of health insurance among adults aged 18-64 years | null | % | Crude Prevalence | null | null | **** | Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30% | null | null | Race/Ethnicity | Hispanic | null | null | null | null | POINT (-72.51764079099962 43.62538123900049) | null | 50 | OVC | OVC1_1 | CRDPREV | RACE | HIS | null | null | null | null |
2,020 | 2,020 | WY | Wyoming | BRFSS | Cardiovascular Disease | Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with a history of coronary heart disease | null | % | Age-adjusted Prevalence | null | null | **** | Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30% | null | null | Race/Ethnicity | Hispanic | null | null | null | null | POINT (-108.10983035299967 43.23554134300048) | null | 56 | CVD | CVD10_2 | AGEADJPREV | RACE | HIS | null | null | null | null |
2,020 | 2,020 | WY | Wyoming | BRFSS | Cancer | Fecal occult blood test, sigmoidoscopy, or colonoscopy among adults aged 50-75 years | null | % | Crude Prevalence | 63.4 | 63.4 | null | null | 60.6 | 66.1 | Overall | Overall | null | null | null | null | POINT (-108.10983035299967 43.23554134300048) | null | 56 | CAN | CAN3_0 | CRDPREV | OVERALL | OVR | null | null | null | null |